logo

For the Inventor, By the Inventor

Madison, WI, United States of America

Heinrich K Schnoes

This inventor holds 100 USPTO granted patents, plus 9 CIPO patents, primarily in Vitamin D Compounds (CPC class 2603972). Top assignees: Wisconsin Alumni Research Foundation, Howard W. Bremer, Other. Active years: 1977-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinrich K Schnoes. Retrieved from https://idiyas.com/inventor/heinrich-k-schnoes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 100

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.5

ph-index = 20

Forward Citations = 1,228(Granted Patents)

Forward Citations (Not Self Cited) = 1,073(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • botho of Madison, WI (US) (1994)
  • Madison, WI (US) (1977 - 1999)

Company Filing History:

goldMedal95 out of 4,243 
 
Wisconsin Alumni Research Foundation
 patents
silverMedal1 out of 1 
 
Howard W. Bremer
 patent
bronzeMedal4 out of 834,570 
Other
 patents

Years Active: 1977-1999

Loading Chart...
Loading Chart...
Areas of Expertise:
Calcitriol Derivatives
19-Nor-Vitamin D
Vitamin D Compounds
Synthesis Methods
Osteoporosis Treatments
Cell Differentiation
Proliferative Skin Disorders
Homologated Compounds
Dihydroxyvitamin D
Acetylenic Cyclohexane
Intermediate Preparation
Steroid Side Chains
100 patents (USPTO):Explore Patents
1. 5976784 - Calcitriol derivatives and their uses (1999-11-02),
2. 5952317 - Calcitriol derivatives and their uses (1999-09-14),
3. 5880292 - All-trans-retinol metabolite (1999-03-09),
4. 5880113 - 19-nor-vitamin D compounds (1999-03-09),
5. 5856536 - Preparation of 19-Nor-vitamin D compounds (1999-01-05),
6. 5750746 - Homologated vitamin D2 compounds and the corresponding (1998-05-12),
7. 5710294 - 19-nor vitamin D compounds (1998-01-20),
8. 5633241 - 19-nor-vitamin D compounds (1997-05-27),
9. 5618805 - 19-nor-vitamin D compounds (1997-04-08),
10. 5616759 - Cyclohexylidene compounds (1997-04-01),
11. 5616744 - 19-Nor-vitamin D compounds (1997-04-01),
12. 5599958 - Preparation of 19-nor vitamin D compounds (1997-02-04),
13. 5597932 - Intermediate for the preparation of 19-nor vitamin D compounds (1997-01-28),
14. 5587497 - 19-nor-vitamin D compounds (1996-12-24),
15. 5581006 - Synthesis of 19-nor vitamin D compounds (1996-12-03),

Title: The Enduring Legacy of Inventor Heinrich K Schnoes

Introduction:

Inventor Heinrich K Schnoes, based in Madison, WI (US), continues to inspire the next generation of inventors with his passion for pushing the boundaries of what is possible through innovation. His legacy as a pioneering inventor will undoubtedly endure for years to come.

Latest Patents:

Heinrich K Schnoes, with a remarkable tally of 100 patents to his name, has recently been granted patents for Calcitriol derivatives and their uses. These innovative compounds aim to treat metabolic bone diseases such as osteoporosis and other disease states treatable with vitamin D compounds. By administering modified vitamin D compounds with in vivo hydrolyzable groups at specific carbon positions, he has revolutionized the field of controlled release pharmaceuticals.

Career Highlights:

Throughout his illustrious career, Heinrich K Schnoes has been associated with prestigious organizations such as the Wisconsin Alumni Research Foundation. His strategic approach to innovation and unwavering commitment to excellence have set him apart as a visionary inventor in the field of pharmaceuticals and healthcare.

Collaborations:

Heinrich K Schnoes has collaborated with esteemed colleagues such as Hector Floyd Deluca and Kato L Perlman, further enhancing his reputation as a team player and a leader in collaborative innovation. Together, they have contributed significantly to the development of groundbreaking technologies and medical advancements.

Conclusion:

In conclusion, Heinrich K Schnoes stands as a beacon of inspiration for aspiring inventors, showcasing the transformative power of relentless dedication to innovation. His pioneering work in the realm of pharmaceuticals and controlled release compounds underscores his enduring impact on the field. As we look towards the future, Heinrich K Schnoes' legacy will continue to shape the landscape of invention and innovation for generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…